Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194480 · ClinicalTrials.gov registry record · Phase 4
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users
A Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT00194480 is a Phase 4 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 21 participants.
The verdict
NCT00194480, a Phase 4 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
Injection drug use accounts for transmission of a high proportion of Hepatitis C Virus (HCV) infections. The purpose of this trial is to investigate the effectiveness of pegylated interferon in treating injection drug users (IDUs) with acute HCV.
Interventions
- DRUG Pegylated Interferon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2003-04 |
| Est. Completion | 2007-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194480
The ClinicalTrials.gov registry entry for NCT00194480 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pegylated Interferon is the first listed.
NCT00194480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194480 about?
NCT00194480 is a clinical study titled "Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users". Injection drug use accounts for transmission of a high proportion of Hepatitis C Virus (HCV) infections. The purpose of this trial is to investigate the effectiveness of pegylated interferon in treating injection drug users (IDUs) with acute HCV.
What is the current status of trial NCT00194480?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2003-04. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00194480?
The interventions under investigation include: Pegylated Interferon (DRUG).
Who is sponsoring clinical trial NCT00194480?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.